News

Novel dementia vaccine on track for human trials within two years

January 2, 2020/

3D illustration brain nervous system active, medical concept.

The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”

By Rich Haridy


Click here to read the story.

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


Working to create a clean and balanced energy portfolio that will provide for a safe and reliable energy future. Learn more at http://www.NorthWesternEnergy.com/BrightFuture

MATR Supporters (view all)


The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner

Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.